Osaic Holdings’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Osaic Holdings’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-880	Closed	-$33.8K	–	7648
2023 Q2	$33.8K	Sell	880 -292	-25%	-$7.5K	﹤0.01%	5206
2023 Q1	$27.1K	Buy	1,172 +7	+0.6%	+$167	﹤0.01%	5384
2022 Q4	$30K	Buy	1,165 +206	+21%	+$4.56K	﹤0.01%	5299
2022 Q3	$19K	Buy	959 +14	+1%	+$281	﹤0.01%	5633
2022 Q2	$17K	Hold	945	–	–	﹤0.01%	5743
2022 Q1	$15K	Hold	945	–	–	﹤0.01%	5904
2021 Q4	$15K	Buy	945 +660	+232%	+$9.39K	﹤0.01%	6020
2021 Q3	$4K	Sell	285 -63	-18%	-$829	﹤0.01%	6682
2021 Q2	$5K	Buy	348 +283	+435%	+$4.53K	﹤0.01%	6416
2021 Q1	$1K	Hold	65	–	–	﹤0.01%	6728
2020 Q4	$1K	Buy	+65	New	+$981	﹤0.01%	6316

Osaic Holdings's KDNY Position: Q3 2023 in Review

Osaic Holdings sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 880 shares — an estimated $33.8K sold.

Osaic Holdings first reported a position in KDNY in Q4 2020 and held it in 11 quarters. The position peaked at $33.8K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Osaic Holdings reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Osaic Holdings sold 880 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $33.8K.
Osaic Holdings first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Osaic Holdings's Chinook Therapeutics, Inc. Common Stock position peaked at $33.8K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.